Dhana Klodian, Nano Jana, Ligthart Symen, Peeters Anna, Hofman Albert, Nusselder Wilma, Dehghan Abbas, Franco Oscar H
Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Deakin University, Geelong, Victoria, Australia.
PLoS Med. 2016 Jul 19;13(7):e1002086. doi: 10.1371/journal.pmed.1002086. eCollection 2016 Jul.
Overweight and obesity are associated with increased risk of type 2 diabetes. Limited evidence exists regarding the effect of excess weight on years lived with and without diabetes. We aimed to determine the association of overweight and obesity with the number of years lived with and without diabetes in a middle-aged and elderly population.
The study included 6,499 individuals (3,656 women) aged 55 y and older from the population-based Rotterdam Study. We developed a multistate life table to calculate life expectancy for individuals who were normal weight, overweight, and obese and the difference in years lived with and without diabetes. For life table calculations, we used prevalence, incidence rate, and hazard ratios (HRs) for three transitions (healthy to diabetes, healthy to death, and diabetes to death), stratifying by body mass index (BMI) at baseline and adjusting for confounders. During a median follow-up of 11.1 y, we observed 697 incident diabetes events and 2,192 overall deaths. Obesity was associated with an increased risk of developing diabetes (HR: 2.13 [p < 0.001] for men and 3.54 [p < 0.001] for women). Overweight and obesity were not associated with mortality in men and women with or without diabetes. Total life expectancy remained unaffected by overweight and obesity. Nevertheless, men with obesity aged 55 y and older lived 2.8 (95% CI -6.1 to -0.1) fewer y without diabetes than normal weight individuals, whereas, for women, the difference between obese and normal weight counterparts was 4.7 (95% CI -9.0 to -0.6) y. Men and women with obesity lived 2.8 (95% CI 0.6 to 6.2) and 5.3 (95% CI 1.6 to 9.3) y longer with diabetes, respectively, compared to their normal weight counterparts. Since the implications of these findings could be limited to middle-aged and older white European populations, our results need confirmation in other populations.
Obesity in the middle aged and elderly is associated with a reduction in the number of years lived free of diabetes and an increase in the number of years lived with diabetes. Those extra years lived with morbidity might place a high toll on individuals and health care systems.
超重和肥胖与2型糖尿病风险增加相关。关于超重对患糖尿病和未患糖尿病情况下预期寿命的影响,现有证据有限。我们旨在确定中年及老年人群中超重和肥胖与患糖尿病和未患糖尿病情况下生存年数之间的关联。
该研究纳入了基于人群的鹿特丹研究中6499名年龄在55岁及以上的个体(3656名女性)。我们构建了一个多状态生命表,以计算体重正常、超重和肥胖个体的预期寿命,以及患糖尿病和未患糖尿病情况下生存年数的差异。在进行生命表计算时,我们使用了三个转变(健康到糖尿病、健康到死亡、糖尿病到死亡)的患病率、发病率和风险比(HR),按基线体重指数(BMI)分层并对混杂因素进行调整。在中位随访11.1年期间,我们观察到697例糖尿病发病事件和2192例全因死亡。肥胖与患糖尿病风险增加相关(男性HR:2.13 [p < 0.001],女性HR:3.54 [p < 0.001])。超重和肥胖与患糖尿病或未患糖尿病的男性和女性的死亡率均无关。总体预期寿命不受超重和肥胖的影响。然而,55岁及以上的肥胖男性未患糖尿病的生存年数比体重正常个体少2.8年(95%CI -6.1至-0.1),而对于女性,肥胖与体重正常个体之间的差异为4.7年(95%CI -9.0至-0.6)。与体重正常的男性和女性相比,肥胖男性和女性患糖尿病后的生存年数分别多2.8年(95%CI 0.6至6.2)和5.3年(95%CI 1.6至9.3)。由于这些发现的影响可能仅限于欧洲中年及老年白人人群,我们的结果需要在其他人群中得到证实。
中年及老年人群中的肥胖与无糖尿病生存年数减少以及患糖尿病生存年数增加相关。这些因发病而多活的年数可能给个人和医疗保健系统带来沉重负担。